Hsbc Holdings PLC Astrazeneca PLC Transaction History

Hsbc Holdings PLC

$168 Billion
Q3 2024

A detailed history of Hsbc Holdings PLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hsbc Holdings PLC holds 1,815,138 shares of AZN stock, worth $127 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

1,815,138

Previous 1,283,274 41.45%

Holding current value

$127 Million

Previous $100 Million 41.32%

% of portfolio

0.08%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $40.8 Million - $46.6 Million	531,864 Added 41.45%	1,815,138 $141 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $75.7 Million - $91.5 Million	1,132,362 Added 750.35%	1,283,274 $100 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $38.6 Million - $44 Million	-631,948 Reduced 80.72%	150,912 $10.2 Million
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $5.84 Million - $6.54 Million	94,334 Added 13.7%	782,860 $52.7 Million
Q3 2023 Nov 13, 2023	SELL	$64.85 - $71.7 $4.34 Million - $4.8 Million	-66,986 Reduced 8.87%	688,526 $46.6 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $51.7 Million - $56 Million	738,882 Added 4443.07%	755,512 $54.1 Million
Q1 2023 May 15, 2023	SELL	$63.15 - $71.6 $12.1 Million - $13.7 Million	-191,492 Reduced 92.01%	16,630 $1.15 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $11 Million - $14.3 Million	202,755 Added 3777.81%	208,122 $14.1 Million
Q3 2022 Nov 14, 2022	SELL	$53.02 - $135.75 $181,328 - $464,265	-3,420 Reduced 38.92%	5,367 $295,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $91.4 Million - $110 Million	-1,542,791 Reduced 99.43%	8,787 $581,000
Q1 2022 May 16, 2022	SELL	$55.72 - $67.12 $385 Million - $463 Million	-6,902,738 Reduced 81.65%	1,551,578 $104 Million
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $138 Million - $163 Million	2,559,076 Added 43.41%	8,454,316 $492 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $245 Million - $268 Million	4,403,238 Added 295.12%	5,895,240 $356 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $41.4 Million - $51.5 Million	855,918 Added 134.56%	1,492,002 $89.4 Million
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $1.41 Million - $1.63 Million	-29,970 Reduced 4.5%	636,084 $31.6 Million
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $26.6 Million - $31.8 Million	547,654 Added 462.55%	666,054 $33.3 Million
Q3 2020 Nov 12, 2020	BUY	$53.07 - $61.1 $4.37 Million - $5.03 Million	82,264 Added 227.65%	118,400 $6.51 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $410,312 - $526,551	-9,520 Reduced 20.85%	36,136 $1.91 Million
Q1 2020 May 15, 2020	BUY	$37.79 - $51.33 $71,045 - $96,500	1,880 Added 4.29%	45,656 $2.04 Million
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $88,104 - $104,704	-2,075 Reduced 4.53%	43,776 $2.18 Million
Q3 2019 Nov 14, 2019	BUY	$40.12 - $45.47 $187,681 - $212,708	4,678 Added 11.36%	45,851 $2.04 Million
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $17,894 - $20,006	480 Added 1.18%	41,173 $1.7 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $601,803 - $729,490	-16,957 Reduced 29.41%	40,693 $1.65 Million
Q4 2018 Feb 13, 2019	BUY	$36.86 - $41.49 $813,463 - $915,642	22,069 Added 62.02%	57,650 $2.19 Million
Q3 2018 Nov 13, 2018	BUY	$34.76 - $39.72 $88,777 - $101,444	2,554 Added 7.73%	35,581 $1.41 Million
Q2 2018 Aug 10, 2018	SELL	$34.55 - $37.05 $3.99 Million - $4.28 Million	-115,515 Reduced 77.77%	33,027 $1.16 Million
Q1 2018 May 11, 2018	BUY	$32.97 - $36.63 $3.32 Million - $3.68 Million	100,567 Added 209.62%	148,542 $5.19 Million
Q4 2017 Feb 14, 2018	BUY	$32.09 - $34.78 $55,226 - $59,856	1,721 Added 3.72%	47,975 $1.67 Million
Q3 2017 Nov 14, 2017	BUY	$28.96 - $34.0 $334,661 - $392,904	11,556 Added 33.3%	46,254 $1.57 Million
Q2 2017 Aug 14, 2017	BUY	N/A	34,698	34,698 $1.18 Million

Others Institutions Holding AZN

# of Institutions

1,340

Shares Held

476M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $217B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.

Account

Hsbc Holdings PLC Astrazeneca PLC Transaction History